| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Alphatec Holdings, Inc. | EVP, CLINICAL STRATEGIES | Common Stock | 540,098 | $8,101,470 | $15.00 | 05 Aug 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ATEC | Alphatec Holdings, Inc. | 05 Aug 2022 | 1 | -$48,582 | 4 | EVP, CLINICAL STRATEGIES | 09 Aug 2022, 18:00 |
| ATEC | Alphatec Holdings, Inc. | 18 Mar 2022 | 1 | -$32,164 | 4 | EVP, Clinical Strategies | 22 Mar 2022, 16:07 |
| ATEC | Alphatec Holdings, Inc. | 24 Feb 2022 | 2 | $0 | 4 | EVP, Clinical Strategies | 28 Feb 2022, 15:13 |
| ATEC | Alphatec Holdings, Inc. | 05 Aug 2021 | 1 | -$92,142 | 4 | EVP, Clinical Strategies | 09 Aug 2021, 11:14 |
| ATEC | Alphatec Holdings, Inc. | 17 May 2021 | 1 | -$259,545 | 4 | EVP, Clinical Strategies | 19 May 2021, 12:40 |